The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...
Poster highlights robust, dose-dependent endoscopic response with VTX958 and reductions in key inflammatory markersFull analysis of Phase 2 ...
The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...
A newly approved pain medication, suzetrigine, is the first nonopioid analgesic in 25 years to receive clearance from the U.S ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
Colorectal cancer (CRC) is a major health problem, with an alarming increase of early-onset CRC (EO-CRC) cases among individuals under 50 years of age. This trend shows the urgent need for ...
This came after Dr. Reddy's Lab presented the proposal for grant of permission to manufacture and market Esomeprazole Gastro ...
SAN FRANCISCO -- More adults with moderate-to-severe Crohn's disease (CD) reached clinical remission after 6 months on ...
Magnesium glycinate and citrate are two common forms of magnesium supplements. Learn the differences between them and when ...
Initial fasting plasma glucose levels outside of 80 to 94 mg/dL linked to increased risk for diabetes. HealthDay News — Fasting plasma glucose (FPG), age, body mass index (BMI), and male sex are all ...
Kinder unter 12 Jahren: Das Arzneimittel sollte in der Regel in dieser Altersgruppe nicht angewendet werden. Kinder und Jugendliche unter 18 Jahren: In dieser Altersgruppe sollte das Arzneimittel nur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback